Literature DB >> 20701445

Next-generation, genome sequencing-based biomarkers: concerns and challenges for medical practice.

Dimitrios H Roukos.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20701445     DOI: 10.2217/bmm.10.70

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


× No keyword cloud information.
  47 in total

1.  Histology classification challenges for the endoscopic treatment of early gastric cancer.

Authors:  Christof Hottenrott
Journal:  Surg Endosc       Date:  2012-07       Impact factor: 4.584

2.  Laparoscopic gastrectomy and impact on recurrence of gastric cancer.

Authors:  Christof Hottenrott
Journal:  Surg Endosc       Date:  2012-03       Impact factor: 4.584

3.  The long-term efficacy of laparoscopic surgery in early and advanced gastric cancer.

Authors:  Christof Hottenrott
Journal:  Surg Endosc       Date:  2012-04-27       Impact factor: 4.584

4.  Personalized medicine for laparoscopic gastrectomy in gastric cancer.

Authors:  Christof Hottenrott
Journal:  Surg Endosc       Date:  2012-05-02       Impact factor: 4.584

5.  Risk factors and early detection of breast cancer: facts, questions, and genome-based perspectives.

Authors:  Demosthenes E Ziogas
Journal:  Curr Oncol       Date:  2012-06       Impact factor: 3.677

6.  Expanding laparoscopic gastrectomy for gastric cancer outside Korea and Japan.

Authors:  Christof Hottenrott
Journal:  Surg Endosc       Date:  2012-06-26       Impact factor: 4.584

7.  Predictive medicine and esophageal cancer response to preoperative chemotherapy.

Authors:  Christof Hottenrott
Journal:  Surg Endosc       Date:  2012-06-22       Impact factor: 4.584

8.  Adjuvant S-1 chemotherapy for gastric cancer and peritoneal wash.

Authors:  John Spiliotis; Odysseas Zoras
Journal:  World J Surg       Date:  2011-02       Impact factor: 3.352

9.  Metachronous cancer in the stomach remnant.

Authors:  Christos S Katsios
Journal:  World J Surg       Date:  2011-02       Impact factor: 3.352

10.  Two-stage breast cancer screening in the developing world.

Authors:  Charalabos Batsis
Journal:  World J Surg       Date:  2011-03       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.